Dow Down 0.17% Nasdaq Down 0.28%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
26.00 Down 1.03(3.81%) Sep 30, 4:00PM EDT
|After Hours : 26.00 0.00 (0.00%) Sep 30, 7:57PM EDT
Prev Close:27.03
Open:27.11
Bid:25.81 x 100
Ask:N/A
1y Target Est:37.77
Beta:0.08
Next Earnings Date: 5-Nov-14NPSP Earnings announcement
Day's Range:26.00 - 27.31
52wk Range:21.60 - 39.68
Volume:1,713,741
Avg Vol (3m):1,873,820
Market Cap:2.77B
P/E (ttm):1,300.00
EPS (ttm):0.02
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NPSPDown 3.81%2.77B
ABTDown 0.74%62.54B
BIIBUp 0.20%78.12B

Key Statistics

Forward P/E (1 yr):22.61
P/S (ttm):14.86
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.02
Quarterly EPS Est (Sep-14) :0.01
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):11.95

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback